Research programme: HIV booster vaccine - Pepscan Systems
Latest Information Update: 24 May 2012
Price :
$50 *
At a glance
- Originator Pepscan Systems
- Developer Pepscan Therapeutics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 24 May 2012 No development reported - Preclinical for HIV infections in Netherlands (Injection)
- 24 May 2012 No development reported - Preclinical for HIV infections in United Kingdom (Injection)
- 03 Nov 2006 Preclinical trials in HIV infections in Netherlands (unspecified route)